Does Dr. ROGER GOLDBERG have financial conflicts of interest?

Dr. ROGER GOLDBERG (MD) has received a total of $896,671 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $862,506 in personal promotional payouts (consulting, meals, travel) and $34,165 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROGER GOLDBERG?

According to CMS Open Payments data, Dr. ROGER GOLDBERG received funding from APELLIS PHARMACEUTICALS ($256,997), GENENTECH USA ($161,837), and BOEHRINGER INGELHEIM INTERNATIONAL ($125,119).

Does Dr. ROGER GOLDBERG receive research grants or speaking fees?

Dr. ROGER GOLDBERG has received $862,506 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $34,165 in clinical research grants.

DR. ROGER GOLDBERG

MDReal-Time Hydrated

Specialty: Ophthalmology, Retina Specialist

Practice Location: WALNUT CREEK, CA 94598

NPI Number: 1184866584

LIFETIME INDUSTRY VALUE

$896,671

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. GOLDBERG is a verified Ophthalmology, Retina Specialist practitioner based in WALNUT CREEK, CA.

Between 2021 and 2025, Dr. GOLDBERG had an overall industry promotional and research financial footprint of $896,671 as recorded in the federal CMS Open Payments database.

$862,506 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$34,165 was allocated to sponsored clinical trials and medical research activities.

Dr. GOLDBERG's primary funding source is APELLIS PHARMACEUTICALS, which accounts for $256,997 (representing 28.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

APELLIS PHARMACEUTICALS

Rank 1

$256,997

28.7%

GENENTECH USA

Rank 2

$161,837

18%

BOEHRINGER INGELHEIM INTERNATIONAL

Rank 3

$125,119

14%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.